Comparing Cefepime and Piperacillin-Tazobactam for Acute Infections in Hospitalized Adults

A randomized clinical trial compared the safety of cefepime and piperacillin-tazobactam, two commonly used antibiotics for treating acute infection in hospitalized adults. The study found that the risk of acute kidney injury did not differ significantly between the two drugs, but patients treated with cefepime experienced more neurological dysfunction. These findings provide valuable insights into the comparative safety profiles of these antibiotics in the treatment of acute infection.